Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Airway Gas Sampling Products are intended for continuous monitoring of expired and inspired respiratory gases. The Airway Gas Sampling Products are single patient use devices with a cumulative duration of use of up to 72 hours.

    The Airway Gas Sampling Products include Airway Gas Sampling Sets with integrated gas sampling lines, and an Airway Adapter without sample line, both for use with compatible GE Healthcare sidestream respiratory gas modules and patient monitors utilizing these modules.

    The Airway Gas Sampling Sets are provided in two sizes: large for use with adult/pediatric patients, and small for use with infant patients, for connection to the patient's breathing circuit. They are provided in two lengths: 3 meter/10 feet, and 2 meter/7 feet. The Airway Gas Sampling Sets are intended for continuous monitoring of Carbon Dioxide (CO2), Oxygen (O2), and respiratory rate in professional/hospital care environments where agents are NOT used, such as intensive care units (ICU), emergency department (ED), coronary care unit (CCU), post anesthesia care unit (PACU) and in-hospital patient transport.

    The Airway Adapter is provided in a large size for use with adult/pediatric patients, for connection to the patient's breathing circuit, and may be used with separately supplied gas sample lines. The Airway Adapter is intended for professional use environments and applications specified for the connected respiratory gas modules and patient monitors.

    The Airway Gas Sampling Products are intended for use by qualified medical personnel only. Prescription use only.

    Device Description

    The Bluepoint Medical disposable Airway Gas Sampling Products offered in this submission are specified for use with compatible GE Healthcare side stream respiratory gas modules and patient monitors utilizing these modules.

    The Airway Gas Sampling Products include two product series:

    • . Disposable Airway Gas Sampling Sets with airway adapter and integrated side stream TPE gas sampling lines
    • . Disposable Airway Adapter with female Luer Connector and without sample line

    The Airway Gas Sampling Sets are offered in both Adult/Pediatric and Infant airway sizes. Two lengths of the Adult/Pediatric size are offered: 3m/10ft, and 2m/7ft. The Infant size is offered in 2m/7ft.

    The Airway Gas Sampling Sets are constructed with the following features:

    • . Rigid clear medical grade plastic airway adapter designed for connection to patient breathing circuit
    • . TPE (thermoplastic elastomer) gas sampling lines with moisture management properties that support their specified use duration of up to 72 hours
    • . Molded male Luer connector for attachment to GE Healthcare respiratory gas modules

    The Airway Adapter without sample line is offered in an Adult/Pediatric size, and includes a molded female Luer connector for attachment of a clinician-selected gas sample line.

    All devices are disposable and labeled for single patient use.

    AI/ML Overview

    The provided text describes the acceptance criteria and the studies performed for the Bluepoint Medical Airway Gas Sampling Products, but it does not contain information typically associated with AI/ML device studies, such as training sets, test sets, expert adjudication, or MRMC studies. This is a medical device clearance, not an AI/ML software clearance.

    Based on the document, here's the information regarding the acceptance criteria and a detailed description of the studies:

    1. A table of acceptance criteria and the reported device performance

    Acceptance Criteria CategoryReported Device Performance
    BiocompatibilityThe devices met the acceptance criteria for biocompatibility and acceptable risk, as evaluated against ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO 18562-1, ISO 18562-2, ISO 18562-3, and a comprehensive inhalation risk assessment in accordance with ISO 10993-17.
    Performance Testing (Accuracy)For CO2 and O2, total system response time (per ISO 80601-2-55) was < 3.0 seconds with Carescape module. The devices met acceptance criteria for accuracy, sampling delay, and rise time (sub-parts of ISO 80601-2-55).
    Performance Testing (Moisture Management/Duration of Use)Extended time (72 hour) moisture testing verified that the moisture management properties of the devices meet the specified duration of use (up to 72 hours). The devices met the acceptance criteria for integration and performance.
    Compliance Standards (Conical Connectors)The devices met the acceptance criteria for applicable parts of ISO 5356-1.
    Compliance Standards (Luer Taper Connections)The devices met the acceptance criteria for applicable parts of ISO 594-1 and ISO 594-2.
    Risk ManagementRisk management, risk, and hazard analysis were performed according to ISO 14971. The devices met the acceptance criteria for residual risks.

    2. Sample size used for the test set and the data provenance

    The document does not specify exact sample sizes for each test mentioned (e.g., how many units were tested for biocompatibility or performance). It generally states that "Performance testing was executed on new device samples and on samples that have undergone accelerated aging to the duration of the proposed shelf life of three years." Data provenance is not mentioned beyond the fact that the tests were performed by Bluepoint Medical GmbH & Co. KG.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not applicable and is not provided in the document. The studies performed are engineering and laboratory tests based on established medical device standards, not human expert evaluations of medical images or data.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not applicable and is not provided in the document. The studies performed are objective laboratory and engineering tests, not subjective evaluations requiring adjudication.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No such study was done. This device is a passive medical accessory (airway gas sampling product), not an AI/ML diagnostic or assistive device that would involve human readers or AI assistance.

    6. If a standalone (i.e. algorithm only, without human-in-the-loop performance) was done

    This information is not applicable as the device is a physical medical accessory, not an algorithm or software. It does not have a "standalone" algorithmic performance.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    The "ground truth" for the device's performance is established by recognized international standards and specifications for medical devices. For example:

    • Biocompatibility: Determined by adherence to ISO 10993 series and ISO 18562 series, along with chemical characterization and inhalation risk assessment.
    • Performance (Accuracy, Response Time): Determined by meeting specific thresholds set by ISO 80601-2-55 for respiratory gas monitors.
    • Physical Compatibility: Determined by adherence to ISO 5356-1, ISO 594-1, and ISO 594-2 for various connectors.
    • Risk Management: Determined by compliance with ISO 14971.

    8. The sample size for the training set

    This information is not applicable and is not provided. The development and testing of this type of medical device do not typically involve "training sets" in the context of AI/ML. The device is designed and validated through engineering principles and compliance with standards.

    9. How the ground truth for the training set was established

    This information is not applicable. There is no concept of a "training set" or "ground truth" for a training set in the context of this device's development as described in the document.

    In summary: The provided document describes the clearance of a non-AI/ML medical device. The acceptance criteria and testing are focused on demonstrating compliance with established physical, mechanical, and biological safety standards for medical accessories. Therefore, many of the questions related to AI/ML device studies (training sets, expert adjudication, MRMC studies) are not applicable to this submission.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nellcor Flexible SpO2 Sensors, models FLEXMAX and FLEXMAX-P, are indicated for use with monitoring systems that use Nellcor OxiMax and Nellcor compatible pulse oximeters.

    The Nellcor Flexible SpO2 Sensors are intended for use in non-invasive continuous or spot-check monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. The sensor size range includes a large and small sensor. The sensors are intended for use on adult and pediatric (excluding infant and neonatal) patients weighing greater than 20kg.

    The use environment may include: hospital-type facilities, intra-hospital transport, mobile emergency medical applications including both ground and air transport, and home use. Transport environments may include intra-hospital transport and both ground and air emergency transport: road ambulances and fixed-wing aircraft and helicopters. The use is dependent upon the use environments specified for the monitoring system utilized in conjunction with the sensor.

    The Nellcor Flexible SpO2 Sensors are for prescription use only.

    Device Description

    Bluepoint Medical's Nellcor-branded reusable Flexible SpO2 Sensors models FLEXMAX and FLEXMAX-P are pulse oximeter sensors designed and validated for compatibility with Nellcor pulse oximetry and monitoring systems.

    Bluepoint Medical reusable Nellcor Flexible SpO2 Sensors models FLEXMAX and FLEXMAX-P are designed for the same functionality as the predicate device sensors, measuring functional oxygen saturation using the patient's finger as the measurement site. They are constructed with the following features:

    • Unitary flexible silicone rubber housing containing the optical transmitter l and detector
    • . Sensor and cable are immersible for cleaning and disinfection
    • . Jacketed and shielded medical grade cable with ferrite for EMC suppression
    • . Manufacturer specific connector with sensor labeling for compatibility with Nellcor pulse oximetry and monitoring systems

    The reusable Nellcor Flexible SpO2 Sensors are offered in two models corresponding to two sizes:

    • . FLEXMAX: Reqular Size, with 40 mm housing width
    • FLEXMAX-P: Small Size, with 38 mm housing width

    Additionally, two models are packaged specifically for homecare:

    • . FLEXMAX-HC: Flexible SpO2 finger Sensor, Regular, Homecare
    • FLEXMAX-P-HC: Flexible SpO2 finger Sensor. Small. Homecare .

    The homecare sensor models with -HC designation are identical in all respects to their professional use counterparts, however the sensors are packaged to additionally include the Home Use Guide for lay users.

    AI/ML Overview

    The document provided describes the Nellcor Flexible SpO2 Sensors models FLEXMAX and FLEXMAX-P. Here is an analysis of its acceptance criteria and the study details:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criterion (SpO2 Accuracy)Reported Device Performance (SpO2 Accuracy)
    ARMS ≤ 2.5% (This is inferred from the comparison table for the predicate device, as the submission states the new device matches the predicate's technological characteristics. The document explicitly states the new device met the acceptance criteria for clinical accuracy according to ISO 80601-2-61 and FDA guidance.)Clinical test results support the stated accuracy claims for the specified range of 70% to 100% SaO2. (The specific ARMS value for the new device itself is not directly stated in the summary, but it implies it met the standard's requirements, which typically involves an ARMS ≤ 3.5% for adult subjects.)
    Acceptance Criterion (Pulse Rate Accuracy)Reported Device Performance (Pulse Rate Accuracy)
    ± 3 BPMThe sensors met the acceptance criteria for pulse rate accuracy.
    Acceptance Criterion (Electrical Safety)Reported Device Performance (Electrical Safety)
    Compliance with IEC 60601-1The sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (EMC)Reported Device Performance (EMC)
    Compliance with IEC 60601-1-2The sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (Home Healthcare Environment)Reported Device Performance (Home Healthcare Environment)
    Compliance with IEC 60601-1-11The sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (Emergency Medical Services Environment)Reported Device Performance (Emergency Medical Services Environment)
    Compliance with IEC 60601-1-12The sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (Pulse Oximeters Specific Requirements)Reported Device Performance (Pulse Oximeters Specific Requirements)
    Compliance with ISO 80601-2-61The sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (Environmental Testing)Reported Device Performance (Environmental Testing)
    Compliance with IEC 60601-1-11 and IEC 60601-1-12 test levelsThe sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (Mechanical Testing)Reported Device Performance (Mechanical Testing)
    Compliance with ISO 80601-2-61 and IEC 60601-1-12 test levelsThe sensors met the acceptance criteria for compliance to the standards.
    Acceptance Criterion (Risk Management)Reported Device Performance (Risk Management)
    Compliance with ISO 14971 (residual risks acceptable)The sensors met the acceptance criteria for residual risks.
    Acceptance Criterion (Usability)Reported Device Performance (Usability)
    Compliance with IEC 60601-1-6, IEC 62366, and FDA Human Factors and Usability GuidanceThe sensors met the acceptance criteria for usability.
    Acceptance Criterion (Biocompatibility)Reported Device Performance (Biocompatibility)
    Compliance with ISO-10993-1, ISO-10993-5 and ISO-10993-10The sensor materials met the acceptance criteria for biocompatibility.
    Acceptance Criterion (Cleaning and Disinfection)Reported Device Performance (Cleaning and Disinfection)
    Compliance with ISO 15583-5, AAMI TIR12, AAMI TIR30, FDA Guidance for Reprocessing Medical DevicesThe sensor materials met the acceptance criteria for cleaning and disinfection.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size for Test Set: The document mentions "healthy adult subjects" for the clinical study but does not specify the exact number of subjects.
    • Data Provenance: The clinical study was a "controlled hypoxia study" conducted under an "institutionally approved protocol." The document does not explicitly state the country of origin, but the submission is to the US FDA, implying the study was conducted to meet US regulatory requirements. It is a prospective study given the nature of a controlled hypoxia experiment.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • The ground truth for SpO2 accuracy was determined by "arterial oxygen saturation determined by co-oximetry." Co-oximetry is a laboratory measurement, not typically established by human experts. The document does not refer to experts for ground truth establishment.

    4. Adjudication Method for the Test Set

    • Not applicable, as ground truth was established by co-oximetry, not expert consensus requiring adjudication.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs without AI Assistance

    • No, an MRMC comparative effectiveness study was not done. This device is a pulse oximeter sensor, not an AI-assisted diagnostic tool that would typically involve human reader performance evaluation.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

    • Yes, the clinical accuracy study was a standalone performance evaluation of the device. The sensor's output was compared directly against co-oximetry measurements during controlled hypoxia, independent of human interpretation or intervention beyond standard monitoring procedures.

    7. The Type of Ground Truth Used

    • The ground truth for SpO2 accuracy in the clinical study was co-oximetry performed on arterial blood samples.

    8. The Sample Size for the Training Set

    • The document does not mention a training set sample size. This is expected as the device is a medical sensor, not a machine learning or AI algorithm that typically requires a separate training set.

    9. How the Ground Truth for the Training Set Was Established

    • Not applicable, as there is no mention of a training set for this device.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1